EMBO Molecular Medicine
| EMBO Molecular Medicine
|
|
|---|---|
| description | Peer-reviewed journal |
| Area of Expertise | Medicine and molecular biology |
| language | English |
| publishing company | Wiley-Blackwell ( Germany ) |
| First edition | 2009 |
| Frequency of publication | twelve issues a year |
| Web link | Website of the journal |
| ISSN (print) | 1757-4676 |
EMBO Molecular Medicine , abbreviated to EMBO Mol. Med. , Is a scientific journal published by Wiley-Blackwell-Verlag on behalf of the European Molecular Biology Organization as an open access online journal. The magazine is currently published twelve times a year. Works are published that come from the border area between molecular biology and clinical research. The focus is on genetics , gene therapy, cancer research and immunology. The editor-in-chief is Stefanie Dimmeler .
The impact factor in 2014 was 8,665. According to the statistics of the ISI Web of Knowledge , the journal with this impact factor ranks ninth out of 123 journals in the experimental and research-based medicine category.
Individual evidence
- ↑ website of the journal ; accessed on September 6, 2015.
- ↑ 2014 Journal Citation Reports, Science Edition (Thomson Reuters, 2015).